Forte Biosciences (FBRX) Treasury Shares (2020 - 2026)
Forte Biosciences (FBRX) reported Treasury Shares of $391437.0 for Q1 2026, up 1159.17% year-over-year from $31087.0 in Q1 2025, and up 728.67% quarter-over-quarter from $47237.0 in Q4 2025.
Forte Biosciences (FBRX) Treasury Shares (2020 - 2026) Analysis & Trends
Forte Biosciences (FBRX) has 7 years of Treasury Shares data on file, last reported at $391437.0 in Q1 2026.
- Treasury Shares for Q1 2026 came in at $391437.0, up 1159.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $391437.0 (up 1159.17% YoY), and the FY2025 annual result was $47237.0, up 65.53% from the prior year.
- Treasury Shares climbed to $391437.0 in Q1 2026 per FBRX's latest filing, from $47237.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $1.3 million in Q1 2023 and troughed at $24387.0 in Q3 2025.
- A 5-year average of $400179.7 and a median of $162201.0 in 2022 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2024: Treasury Shares soared 1625.67% in 2022, then plunged 97.24% in 2024.
- A 5-year view of Treasury Shares shows it stood at $162201.0 in 2022, then tumbled by 73.96% to $42237.0 in 2023, then plunged by 32.44% to $28537.0 in 2024, then soared by 65.53% to $47237.0 in 2025, then surged by 728.67% to $391437.0 in 2026.
- Business Quant data shows FBRX's Treasury Shares at $391437.0 in Q1 2026, $47237.0 in Q4 2025, and $24387.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Forte Biosciences | 70.77 Mn | 12.55 Mn | - | 391,437.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 391,437.00 |
| Mar 31, 2026 | 391,437.00 |
| Dec 31, 2025 | 47,237.00 |
| Dec 31, 2025 | 47,237.00 |
| Sep 30, 2025 | 24,387.00 |
| Sep 30, 2025 | 24,387.00 |
| Jun 30, 2025 | 51,537.00 |
| Jun 30, 2025 | 51,537.00 |
| Mar 31, 2025 | 31,087.00 |
| Mar 31, 2025 | 31,087.00 |
| Dec 31, 2024 | 28,537.00 |
| Dec 31, 2024 | 28,537.00 |
| Sep 30, 2024 | 30,987.00 |
| Sep 30, 2024 | 30,987.00 |
| Jun 30, 2024 | 835,951.00 |
| Jun 30, 2024 | 835,951.00 |
| Mar 31, 2024 | 897,201.00 |
| Mar 31, 2024 | 897,201.00 |
| Dec 31, 2023 | 42,237.00 |
| Dec 31, 2023 | 42,237.00 |